STUDY REVEALS HRT MAY INTERFERE WITH CANCER DETECTION IN WOMEN

A study published in the May issue of Cancer Epidemiology Biomarkers and Prevention found that women on hormone replacement therapy (HRT) are more likely to record "false negatives" during routine mammograms than women who are not on HRT.

Increased breast density (the glandular tissue that appears white on a mammogram), which is high in young women and some of those on HRT makes tumor detection more difficult.

The study results indicate that approximately 5 percent of the women participating in the test who were on HRT had cancers that were not initially detected by mammogram and only 66 percent of the HRT sample had their cancer "at the first round of mammography" as opposed to 82 percent of the non-HRT sample.

buy gyne-lotrimin

This entry was posted in Legal News. Bookmark the permalink.


© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.